Clementina Dellomonaco is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered microorganisms for chemical production. With a total of 2 patents, her work showcases her innovative spirit and dedication to advancing scientific knowledge.

Latest Patents

One of her latest patents focuses on the reverse beta oxidation pathway. This invention relates to recombinant microorganisms that have been engineered to produce various chemicals using genes that have been repurposed to create a reverse beta oxidation pathway. The beta oxidation cycle is expressed and driven in reverse by modifying various regulation points for as many cycles as needed. The CoA thioester intermediates are then converted to useful products by the action of termination enzymes. This groundbreaking work has the potential to revolutionize the way chemicals are produced in the industry.

Career Highlights

Clementina Dellomonaco is affiliated with William Marsh Rice University, where she continues to push the boundaries of research and innovation. Her career is marked by a commitment to exploring new methodologies in biotechnology and contributing to the scientific community.

Collaborations

Throughout her career, Clementina has collaborated with notable colleagues, including James M Clomburg and Elliot N Miller. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in their respective fields.

Conclusion

Clementina Dellomonaco's work exemplifies the spirit of innovation in biotechnology. Her contributions, particularly in the area of engineered microorganisms, highlight her role as a leading inventor in her field. Her ongoing research promises to have a lasting impact on chemical production and biotechnology.